In this study, we assessed the frequencies of peripheral CD3−CD56+ NK cells as a subtype of NK cells and showed that patients with invasive NFPAs had significantly lower percentage of CD3−CD56+ NK cells than patients with noninvasive NFPAs and healthy controls, and less tumor infiltration of CD56+ cells than patients with noninvasive NFPAs. This evidence concerns the gene NCAM1 and neoplasm.